Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Chubb
Daiichi Sankyo
Dow
Covington
Federal Trade Commission
UBS
Colorcon
Mallinckrodt
Merck

Generated: January 19, 2018

DrugPatentWatch Database Preview

ZOSYN IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Zosyn In Plastic Container, and when can generic versions of Zosyn In Plastic Container launch?

Zosyn In Plastic Container is a drug marketed by Wyeth Pharms Inc and is included in one NDA. There are four patents protecting this drug.

This drug has fifty-four patent family members in thirty-three countries.

The generic ingredient in ZOSYN IN PLASTIC CONTAINER is piperacillin sodium; tazobactam sodium. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.
Summary for ZOSYN IN PLASTIC CONTAINER
Drug patent expirations by year for ZOSYN IN PLASTIC CONTAINER
Pharmacology for ZOSYN IN PLASTIC CONTAINER

US Patents and Regulatory Information for ZOSYN IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Wyeth Pharms Inc ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ZOSYN IN PLASTIC CONTAINER

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,498,312 Compositions containing piperacillin and tazobactam useful for injection ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ZOSYN IN PLASTIC CONTAINER

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
UBS
Dow
QuintilesIMS
Johnson and Johnson
Chinese Patent Office
Teva
Argus Health
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot